3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
3
Breast Neoplasms
3
Cognitive Dysfunction
2
Stroke
1
Smoking Cessation
1
Smoking
1
Pain
1
Motor Activity
1
Lymphoma, Follicular
1
Hemianopsia
1
Depression
1
Cognition Disorders
1
Cancer Pain
1
Breast Cancer Survivors
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Bone Neoplasms
1
Blindness, Cortical
1
Anxiety Disorders
1
Interventions
Radiosurgery
50
Magnetic Resonance Spectroscopy
34
Temozolomide
28
Bevacizumab
24
pembrolizumab
23
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
Blood Specimen Collection
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Transcranial Direct Current Stimulation
×
1 year
×
Clear all
NCT07105358
2025-08-05
VIBRANT
Georgetown University
Phase NA
Recruiting
30 enrolled